Sign In
Buy FMS
$20.90
+0.350 (+1.70%)
At Close: Jun 03, 2026
HCA Healthcare (HCA) Received its Third Buy in a Row
03:51pm, Wednesday, 22'nd Apr 2020
After Barclays and Robert W. Baird gave HCA Healthcare (NYSE: HCA) a Buy rating last month, the company received another Buy, this time from RBC Capital.
Fresenius Medical Care AG & Co.'s (FMS) Hold Rating Reaffirmed at Royal Bank of Canada
10:44am, Wednesday, 22'nd Apr 2020
Fresenius Medical Care AG & Co. (NYSE:FMS)‘s stock had its “hold” rating reaffirmed by equities research analysts at Royal Bank of Canada in a research report issued to clients and investors on
Cara Therapeutics Itching Drug Scratches Off Goals of Phase 3 Test
08:52pm, Tuesday, 21'st Apr 2020
A Cara Therapeutics drug developed to treat the severe itching experienced by patients receiving hemodialysis has met the main goal of a second late-stage
Statistically significant improvement in primary endpoint of proportion of patients with three point or greater reduction in mean worst itching intensity NRS score vs. placebo (p=0.02) Statisticall…
Statistically significant improvement in primary endpoint of proportion of patients with three point or greater reduction in mean Worst Itching Intensity NRS score vs. placebo.
Regulatory News:
Fresenius Medical Clears Key Benchmark, Hitting 80-Plus RS Rating
12:00am, Tuesday, 21'st Apr 2020Brookdale (BKD) Receives a Hold from RBC Capital
01:35pm, Monday, 20'th Apr 2020
In a report released today, Frank Morgan from RBC Capital maintained a Hold rating on Brookdale (BKD), with a price target of $4.00. The company's shares
Brookdale (BKD) Receives a Hold from RBC Capital
01:34pm, Monday, 20'th Apr 2020
In a report released today, Frank Morgan from RBC Capital maintained a Hold rating on Brookdale (BKD – Research Report),
RBC Capital Remains a Buy on Surgery Partners (SGRY)
01:34pm, Monday, 20'th Apr 2020
In a report released today, Frank Morgan from RBC Capital maintained a Buy rating on Surgery Partners (SGRY), with a price target of $14.00. The company's
RBC Capital Remains a Buy on Surgery Partners (SGRY)
01:34pm, Monday, 20'th Apr 2020
In a report released today,
Frank Morgan
from RBC Capital maintained a
Buy
rating on Surgery Partners (
SGRY
–
Research Report
), with a price target of
$14.00
. The company’s shares closed last M
RBC Capital Remains a Buy on Select Medical (SEM)
01:34pm, Monday, 20'th Apr 2020
RBC Capital analyst Frank Morgan maintained a Buy rating on Select Medical (SEM) today and set a price target of $26.00. The company's shares closed last
RBC Capital Remains a Buy on Select Medical (SEM)
01:34pm, Monday, 20'th Apr 2020
RBC Capital analyst
Frank Morgan
maintained a
Buy
rating on Select Medical (
SEM
–
Research Report
) today and set a price target of
$26.00
. The company’s shares closed last Monday at $16.00.
Acc
Pennant Group (PNTG) Gets a Hold Rating from RBC Capital
01:34pm, Monday, 20'th Apr 2020
In a report released today, Frank Morgan from RBC Capital maintained a Hold rating on Pennant Group (PNTG), with a price target of $26.00. The company's
